Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

HER2/EGFR in Cancer Research

17 та иш

  1. Morphological Features of Tumor in Different Treatment Options for Patients with Locally Advanced Breast Cancer

    Khodjaeva Dilrukh Ilkhomovna

    МақолаMonoclonal and Polyclonal Antibodies Research20212 иқтибос
    ABI

  2. Pharmacological Evaluation of F45 on the Cardiovascular System Using In Vitro, In Vivo Models and Molecular Dockings

    Ikbolkhon Abdurazakova, Anvar Zaynabiddinov, Izzatullo Abdullaev +6

    МақолаCardiac Imaging and DiagnosticsTrends in Sciences20252 иқтибос
    ABI

  3. Radioiodination and biodistribution of the monoclonal antibody TU-20 and its scFv fragment

    Veronika Kleinová, Hana Chaloupková, Helena Švecová +1

    МақолаMonoclonal and Polyclonal Antibodies ResearchJournal of Radioanalytical and Nuclear Chemistry20100 иқтибос
    ABI

  4. 1141 Clinical Use of HER2 Extracellular Domain as a Marker to Monitor Cancer Status and Predict the Response to Anti-cancer Treatment in Breast Cancer

    Keiichi Kontani, S. Hashimoto, Chisa Murazawa +4

    МақолаHER2/EGFR in Cancer ResearchEuropean Journal of Cancer20120 иқтибос
    ABI

  5. 8-Oxoberberrubine

    Shakhnoza S. Azimova, Marat S. Yunusov

    БобChronic Lymphocytic Leukemia Research20120 иқтибос
    ABI

  6. (−)-Tetrahydroberberrubine

    Shakhnoza S. Azimova, Marat S. Yunusov

    БобCancer Treatment and Pharmacology20120 иқтибос
    ABI

  7. 101P Concentrations of soluble form of epidermal growth factor (oncoprotein SP 185) in systemic therapy

    L. Alimkhodjaeva, Н. А. Махмудова

    МақолаHER2/EGFR in Cancer ResearchAnnals of Oncology20150 иқтибос
    ABI

  8. Morphological features of tumor in different treatment options for patients With Locally Advanced Breast Cancer

    Narzieyva D.F, Jonibekov J. J, Erkinova Sh.N

    МақолаHER2/EGFR in Cancer ResearchMiddle European Scientific Bulletin20200 иқтибос
    ABI

  9. Effect of combined carriage of polymorphic markers ApoE (Ε2/Ε3/Ε4) and ApoA1 (G-75A) on the ApoB/ApoA-I ratio in CAD patients in the Uzbek population

    Р Алиева, Aleksandr B. Shek, А. А. Абдуллаев +4

    МақолаAntiplatelet Therapy and Cardiovascular DiseasesAtherosclerosis20230 иқтибос
    ABI

  10. APPROACHES TO THE TREATMENT OF METASTATIC BREAST CANCER

    Umida Ismailova Abdullayevna, Atahanova Nigora Ergashevna, Kurbankulov Uktam Muhammadovich +1

    МақолаCancer Treatment and PharmacologyTexas Journal of Medical Science20240 иқтибос
    ABI

  11. Is early inclusion of neratinib with HER blockers possible in the treatment of stage 4 HER2 positive cancer?

    Zilola Avazovna Olimova

    МақолаHER2/EGFR in Cancer ResearchJournal of Clinical Oncology20240 иқтибос
    ABI

  12. A clinical case of treatment of recurrent inoperable locally advanced breast cancer using conformal radiotherapy. Case report

    С. В. Медведев, M. Yu. Vlasova, Л. В. Болотина +10

    МақолаBreast Cancer Treatment StudiesJournal of Modern Oncology20250 иқтибос
    ABI

  13. Design, synthesis, and evaluation of novel quinazoline derivatives as potent EGFR inhibitors: In silico and in vitro approaches

    Mohamed J. Saadh, Tamara Nazar Saeed, Karar H. Alfarttoosi +9

    МақолаQuinazolinone synthesis and applicationsComputers in Biology and Medicine20250 иқтибос
    ABI

  14. INTEGRATED THERAPEUTIC STRATEGIES AND PERSONALIZED APPROACHES IN THE MANAGEMENT OF LUMINAL B HER2-NEGATIVE BREAST CANCER: A CLINICAL-STATISTICAL ANALYSIS

    Sevara Alimbayeva, Dilmurod Axadullayev, Akhmadjan Madaminov

    МақолаBreast Cancer Treatment StudiesOpen MIND20260 иқтибос
    ABI

  15. INTEGRATED THERAPEUTIC STRATEGIES AND PERSONALIZED APPROACHES IN THE MANAGEMENT OF LUMINAL B HER2-NEGATIVE BREAST CANCER: A CLINICAL-STATISTICAL ANALYSIS

    Sevara Alimbayeva, Dilmurod Axadullayev, Akhmadjan Madaminov

    МақолаBreast Cancer Treatment StudiesZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  16. 208 Correlation of HER2 FISH Status with Hormone Receptors, Ki-67, and Histologic Grade in Breast Carcinomas with HER2 IHC 2+ among Women in Uzbekistan

    Mirzabek Shodmonov Isokul Ugli, Madina Jakhongirova, Natalya Pak +3

    МақолаHER2/EGFR in Cancer ResearchLaboratory Investigation20260 иқтибос
    ABI

  17. Molecular Mechanisms of Mammary Carcinogenesis: Current Understanding and Prospects for Targeted Therapy

    Ruzibakieva M.R., Jangavorov A.J., Ramziddinov J.J. +2

    МақолаAdvanced Breast Cancer TherapiesInternational Journal of Medical Science and Public Health Research20260 иқтибос
    ABI